Phase II Trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy

被引：1

作者：

Wenham, R. ^{[1
]}

LaPolla, J. ^{[2
]}

Hui-Yi, L. ^{[1
]}

Apte, S. ^{[1
]}

Roberts, W. ^{[1
]}

Lancaster, J. ^{[1
]}

Bosquet, J. Gonzalez ^{[1
]}

Theodore, S. ^{[1
]}

Havrilesky, L. ^{[3
]}

Alvarez-Secord, A. ^{[3
]}

机构：

[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA

[2] Womens Canc Associates, St Petersburg, FL USA

[3] Duke Univ, Med Ctr, Durham, NC USA

来源：

GYNECOLOGIC ONCOLOGY | 2011年 / 121卷 / 01期

关键词：

D O I：

10.1016/j.ygyno.2010.12.199

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

192

引用

页码：S83 / S84

页数：2

共 50 条

[41] A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy [J].

Leary, Alexandra ;

Assersohn, L. ;

Cunningham, D. ;

Norman, A. R. ;

Chong, G. ;

Brown, G. ;

Ross, P. J. ;

Costello, C. ;

Higgins, L. ;

Oates, J. .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (03) :455-462

[42] A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy [J].

Alexandra Leary ;

L. Assersohn ;

D. Cunningham ;

A. R. Norman ;

G. Chong ;

G. Brown ;

P. J. Ross ;

C. Costello ;

L. Higgins ;

J. Oates .

Cancer Chemotherapy and Pharmacology, 2009, 64 :455-462

[43] Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial [J].

Pujade-Lauraine, Eric ;

Hilpert, Felix ;

Weber, Beatrice ;

Reuss, Alexander ;

Poveda, Andres ;

Kristensen, Gunnar ;

Sorio, Roberto ;

Vergote, Ignace ;

Witteveen, Petronella ;

Bamias, Aristotelis ;

Pereira, Deolinda ;

Wimberger, Pauline ;

Oaknin, Ana ;

Mirza, Mansoor Raza ;

Follana, Philippe ;

Bollag, David ;

Ray-Coquard, Isabelle .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (13) :1302-+

[44] Second-line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy - A phase II trial [J].

Tas, F ;

Demir, C ;

Camlica, H ;

Ustuner, Z ;

Topuz, E .

MEDICAL ONCOLOGY, 2004, 21 (03) :233-240

[45] A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens [J].

C N Krasner ;

D S McMeekin ;

S Chan ;

P S Braly ;

F G Renshaw ;

S Kaye ;

D M Provencher ;

S Campos ;

M E Gore .

British Journal of Cancer, 2007, 97 :1618-1624

[46] A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens [J].

Krasner, C. N. ;

McMeekin, D. S. ;

Chan, S. ;

Braly, P. S. ;

Renshaw, F. G. ;

Kaye, S. ;

Provencher, D. M. ;

Campos, S. ;

Gore, M. E. .

BRITISH JOURNAL OF CANCER, 2007, 97 (12) :1618-1624

[47] Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy [J].

Arnold, Susanne M. ;

Chansky, Kari ;

Baggstrom, Maria Q. ;

Thompson, Michael A. ;

Sanborn, Rachel E. ;

Villano, John L. ;

Waqar, Saiama N. ;

Hamm, John ;

Leggas, Markos ;

Willis, Maurice ;

Rosales, Joseph ;

Crowley, John J. .

CLINICAL LUNG CANCER, 2020, 21 (04) :357-+

[48] Combination of Bevacizumab and Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: Some Observations About the AURELIA Trial [J].

Tomao, Federica ;

Tomao, Silverio ;

Panici, Pierluigi Benedetti .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (31) :3580-3580

[49] OVARIO, A Phase 2 Study of Niraparib plus Bevacizumab in Advanced Ovarian Cancer Following Front-Line Platinum-Based Chemotherapy with Bevacizumab: Updated Analysis [J].

Hardesty, Melissa ;

Krivak, Thomas ;

Wright, Gail ;

Hamilton, Erika ;

Fleming, Evelyn ;

Belotte, Jimmy ;

Keeton, Erika ;

Wang, Ping ;

Clements, Aine ;

Gray, Heidi ;

Konecny, Gottfried ;

Moore, Richard ;

Richardson, Debra .

GYNECOLOGIC ONCOLOGY, 2022, 166 :S27-S28

[50] Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent platinum-sensitive ovarian cancer [J].

Ferrandina, G ;

Ludovisi, M ;

Dagostino, G ;

Lorusso, D ;

Naldini, A ;

Testa, AC ;

Paris, I ;

Gallotta, V ;

Pozzo, C ;

Scambia, G .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :468S-468S

← 1 2 3 4 5 →